Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 840 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Year : 2014  |  Volume : 18  |  Issue : 6  |  Page : 794-799

Management of Type 2 diabetes in Ramadan: Low-ratio premix insulin working group practical advice

1 BC University Health Board, Glan Clwyd Hospital, Wales
2 Department of Internal Medicine, Etablissement Hospitalo-Universtaire, Oran, Algeria
3 Professor of Diabetes and Internal Medicine, Alexandria University, Alexandria, Egypt
4 Department of Endocrinology, Manipal Hospital, Bangalore, Karnataka, India
5 Department of Endocrinology, GD Diabetes Hospital, Kolkata, West Bengal, India
6 Al-Nour Hospital, Mekkah, Saudi Arabia
7 Dasman Diabetes Institute, Dasman, Kuwait
8 Diabetes Center Benghazi, Benghazi, Libya
9 Department of Endocrinology, University Hospital Ibn Sina - Rabat, Morocco
10 Department of Endocrinology, Chris Hani Baragwaneth Hospital, University of Witwatersrand, Fordsburg, South Africa
11 National Institute of Nutrition, Tunis, Tunisia
12 Department of Endocrinology, SFAX, Tunisia
13 Dubai Hospital, Dubai Health Authority - DHA, Dubai, United Arab Emirates
14 Rashid Centre for Diabetes and Research, Sheikh Khalifa Hospital, Ajman, United Arab Emirates
15 Internist, EHM, Hoofddorp, Netherlands

Correspondence Address:
Dr. Mohamed Hassanein
BC University Health Board, Glan Clwyd Hospital, Wales

Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2230-8210.140242

Rights and Permissions

The challenge of insulin use during Ramadan could be minimized, if people with diabetes are metabolically stable and are provided with structured education for at least 2-3 months pre-Ramadan. Although, American diabetes association (ADA) recommendations 2010 and South Asian Consensus Guideline 2012 deal with management of diabetes in Ramadan and changes in insulin dosage, no specific guidance on widely prescribed low-ratio premix insulin is currently available. Hence, the working group for insulin therapy in Ramadan, after collective analysis, evaluation, and opinion from clinical practice, have formulated a practical advice to empower physicians with pre-Ramadan preparation, dose adjustment, and treatment algorithm for self-titration of low-ratio premix insulin.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded761    
    Comments [Add]    
    Cited by others 5    

Recommend this journal